Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma

Clinical trial NCT01663012 · COMPLETED

Trial details

NCT number: NCT01663012
Sponsor: Lawrence Recht
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Astrocytomas Anaplastic Oligodendrogliomas Glioblastomas (GBM)

Start date: 2012-07-01
Primary completion: 2015-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.